526 related articles for article (PubMed ID: 27058328)
21. [Comparison of real-time polymerase chain reaction and antigenemia assay to detect cytomegalovirus in pediatric transplants].
Farfán U MJ; Torres T JP; Vergara A A; Donoso W G; Alba G A; Paris D C; Santolaya De P ME
Rev Chilena Infectol; 2011 Apr; 28(2):113-7. PubMed ID: 21720689
[TBL] [Abstract][Full Text] [Related]
22. A prospective study comparing cytomegalovirus antigenemia, DNAemia and RNAemia tests in guiding pre-emptive therapy in thoracic organ transplant recipients.
Lehto JT; Lemström K; Halme M; Lappalainen M; Lommi J; Sipponen J; Harjula A; Tukiainen P; Koskinen PK
Transpl Int; 2005 Dec; 18(12):1318-27. PubMed ID: 16297050
[TBL] [Abstract][Full Text] [Related]
23. Relationship of cytomegalovirus load assessed by real-time PCR to pp65 antigenemia in organ transplant recipients.
Sanghavi SK; Abu-Elmagd K; Keightley MC; St George K; Lewandowski K; Boes SS; Bullotta A; Dare R; Lassak M; Husain S; Kwak EJ; Paterson DL; Rinaldo CR
J Clin Virol; 2008 Aug; 42(4):335-42. PubMed ID: 18495527
[TBL] [Abstract][Full Text] [Related]
24. Monitoring of CMV infection: a comparison of PCR from whole blood, plasma-PCR, pp65-antigenemia and virus culture in patients after bone marrow transplantation.
Hebart H; Müller C; Löffler J; Jahn G; Einsele H
Bone Marrow Transplant; 1996 May; 17(5):861-8. PubMed ID: 8733710
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of the AmpliSensor PCR and the SHARP signal detection system for the early prediction of symptomatic CMV infection in solid transplant recipients.
Rautenberg P; Lübbert C; Weers W; Boetel E; Schweichler J; Zhou L; Costard-Jäckle A; Kraemer-Hansen H; Harder TC
J Clin Virol; 1999 Jun; 13(1-2):81-94. PubMed ID: 10405895
[TBL] [Abstract][Full Text] [Related]
26. Quantification of DNA in plasma by an automated real-time PCR assay (cytomegalovirus PCR kit) for surveillance of active cytomegalovirus infection and guidance of preemptive therapy for allogeneic hematopoietic stem cell transplant recipients.
Gimeno C; Solano C; Latorre JC; Hernández-Boluda JC; Clari MA; Remigia MJ; Furió S; Calabuig M; Tormo N; Navarro D
J Clin Microbiol; 2008 Oct; 46(10):3311-8. PubMed ID: 18753357
[TBL] [Abstract][Full Text] [Related]
27. Quantitation of human cytomegalovirus in recipients of solid organ transplants by real-time quantitative PCR and pp65 antigenemia.
Mengelle C; Pasquier C; Rostaing L; Sandres-Sauné K; Puel J; Berges L; Righi L; Bouquies C; Izopet J
J Med Virol; 2003 Feb; 69(2):225-31. PubMed ID: 12683412
[TBL] [Abstract][Full Text] [Related]
28. [Evaluation of Biosewoom Real-Q Cytomegalovirus Quantification kit for Cytomegalovirus viral load measure].
Heo WB; Won DI; Kim YL; Kim MH; Oh HB; Suh JS
Korean J Lab Med; 2007 Aug; 27(4):298-304. PubMed ID: 18094592
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the Murex Hybrid Capture CMV DNA (v2.0) assay and the pp65 CMV antigenemia test for the detection and quantitation of CMV in blood samples from immunocompromised patients.
Schirm J; Kooistra A; van Son WJ; van der Bij W; Verschuuren E; Sprenger HG; Limburg PC; The TH
J Clin Virol; 1999 Dec; 14(3):153-65. PubMed ID: 10614852
[TBL] [Abstract][Full Text] [Related]
30. Comparison of PCR and pp65 antigenemia assay with quantitative shell vial culture for detection of cytomegalovirus in blood leukocytes from solid-organ transplant recipients.
Storch GA; Buller RS; Bailey TC; Ettinger NA; Langlois T; Gaudreault-Keener M; Welby PL
J Clin Microbiol; 1994 Apr; 32(4):997-1003. PubMed ID: 8027357
[TBL] [Abstract][Full Text] [Related]
31. Comparison of pp65 antigenemia, quantitative PCR and DNA hybrid capture for detection of cytomegalovirus in transplant recipients and AIDS patients.
Mhiri L; Kaabi B; Houimel M; Arrouji Z; Slim A
J Virol Methods; 2007 Jul; 143(1):23-8. PubMed ID: 17336402
[TBL] [Abstract][Full Text] [Related]
32. Real-time PCR assay compared with antigenemia assay for detecting cytomegalovirus infection in kidney transplant recipients.
Kim DJ; Kim SJ; Park J; Choi GS; Lee S; Kwon CD; Ki C; Joh J
Transplant Proc; 2007 Jun; 39(5):1458-60. PubMed ID: 17580161
[TBL] [Abstract][Full Text] [Related]
33. Detection of human cytomegalovirus (HCMV) pp67-mRNA and pp65 antigenemia in relation to development of clinical HCMV disease in renal transplant recipients.
Degré M; Kristiansen KI; Rollag H; Holter E; Nordal KP
Clin Microbiol Infect; 2001 May; 7(5):254-60. PubMed ID: 11422252
[TBL] [Abstract][Full Text] [Related]
34. Validation of clinical application of cytomegalovirus plasma DNA load measurement and definition of treatment criteria by analysis of correlation to antigen detection.
Kalpoe JS; Kroes AC; de Jong MD; Schinkel J; de Brouwer CS; Beersma MF; Claas EC
J Clin Microbiol; 2004 Apr; 42(4):1498-504. PubMed ID: 15070995
[TBL] [Abstract][Full Text] [Related]
35. Comparison of quantitative cytomegalovirus real-time PCR in whole blood and pp65 antigenemia assay: clinical utility of CMV real-time PCR in hematopoietic stem cell transplant recipients.
Choi SM; Lee DG; Lim J; Park SH; Choi JH; Yoo JH; Lee JW; Kim Y; Han K; Min WS; Shin WS; Kim CC
J Korean Med Sci; 2009 Aug; 24(4):571-8. PubMed ID: 19654935
[TBL] [Abstract][Full Text] [Related]
36. Clinical utility of quantitative cytomegalovirus viral load determination for predicting cytomegalovirus disease in liver transplant recipients.
Humar A; Gregson D; Caliendo AM; McGeer A; Malkan G; Krajden M; Corey P; Greig P; Walmsley S; Levy G; Mazzulli T
Transplantation; 1999 Nov; 68(9):1305-11. PubMed ID: 10573068
[TBL] [Abstract][Full Text] [Related]
37. A prospective study comparing quantitative Cytomegalovirus (CMV) polymerase chain reaction in plasma and pp65 antigenemia assay in monitoring patients after allogeneic stem cell transplantation.
Gentile G; Picardi A; Capobianchi A; Spagnoli A; Cudillo L; Dentamaro T; Tendas A; Cupelli L; Ciotti M; Volpi A; Amadori S; Martino P; de Fabritiis P
BMC Infect Dis; 2006 Nov; 6():167. PubMed ID: 17118205
[TBL] [Abstract][Full Text] [Related]
38. A double-blinded, prospective study to define antigenemia and quantitative real-time polymerase chain reaction cutoffs to start preemptive therapy in low-risk, seropositive, renal transplanted recipients.
David-Neto E; Triboni AH; Paula FJ; Vilas Boas LS; Machado CM; Agena F; Latif AZ; Alencar CS; Pierrotti LC; Nahas WC; Caiaffa-Filho HH; Pannuti CS
Transplantation; 2014 Nov; 98(10):1077-81. PubMed ID: 24839894
[TBL] [Abstract][Full Text] [Related]
39. Standardization of Antigenemia and qPCR Cut-off Values in Whole Blood for the Detection of Cytomegalovirus Disease in HIV Patients.
Carstensen S; Raboni SM; França JCB; Teixeira F
Rev Soc Bras Med Trop; 2019 Jun; 52():e20180457. PubMed ID: 31271616
[TBL] [Abstract][Full Text] [Related]
40. Quantitative PCR in the diagnosis of CMV infection and in the monitoring of viral load during the antiviral treatment in renal transplant patients.
Piiparinen H; Helanterä I; Lappalainen M; Suni J; Koskinen P; Grönhagen-Riska C; Lautenschlager I
J Med Virol; 2005 Jul; 76(3):367-72. PubMed ID: 15902704
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
